1-3 of 3
R. J. Baker, MSc
Close
Sort by
Journal Articles

An In Vitro Model of Proliferating CLL Cells for Drug Sensitivity Analysis.

K. Ganeshaguru, PhD, N. I. Folarin, PhD, R. J. Baker, MSc, A. M. Casanova, BSc, A. Bhimjiyani, BSc, A. V. Hoffbrand, DSc, A. B. Mehta, MD, R. G. Wickremasinghe, PhD
Journal: Blood
Blood (2005) 106 (11): 2956.
https://doi.org/10.1182/blood.V106.11.2956.2956
Published: 2005
Journal Articles

Zap-70 and IgV H Mutation Status in Combination with p53 Functional Analysis Identifies the Response of Poor Prognosis B-CLL Patients to Conventional Cytotoxic Agents.

N. I. Folarin, PhD, R. J. Baker, MSc, V. Duke, PhD, B. C. Yogashangary, BSc, C. Vadikolia, MD, R. G. Wickremasinghe, PhD, A. A. Casanova, BSc, M. W. Lowdell, PhD, A. Victor Hoffbrand, DSc, A. Nathwani, MD, A. E. Virchis, MD, A. B. Mehta, MD, L. Foroni, MD, K. Ganeshaguru, PhD
Journal: Blood
Blood (2004) 104 (11): 1907.
https://doi.org/10.1182/blood.V104.11.1907.1907
Published: 2004
Journal Articles

The Role of Multidrug Resistance Proteins and Drug Sensitivity in Relation to Poor Prognosis Identified by ZAP-70 Expression and IgV H Mutation Status in B-CLL.

S. Narat, MD, N. I. Folarin, PhD, R. J. Baker, MSc, V. Duke, PhD, B. C. Yogashangary, BSc, D. T. Jones, PhD, S. M. Hart, PhD, R. G. Wickremasinghe, PhD, A. Victor Hoffbrand, DSc, A. B. Mehta, MD, L. Foroni, MD, K. Ganeshaguru, PhD
Journal: Blood
Blood (2004) 104 (11): 4791.
https://doi.org/10.1182/blood.V104.11.4791.4791
Published: 2004